7-12337210-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001135924.3(VWDE):c.4429C>T(p.Arg1477Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000168 in 1,551,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
VWDE
NM_001135924.3 missense
NM_001135924.3 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 5.34
Genes affected
VWDE (HGNC:21897): (von Willebrand factor D and EGF domains) Predicted to enable signaling receptor binding activity. Predicted to be involved in anatomical structure development. Predicted to be active in cell surface and extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWDE | NM_001135924.3 | c.4429C>T | p.Arg1477Cys | missense_variant | 25/29 | ENST00000275358.8 | NP_001129396.1 | |
VWDE | NM_001346972.2 | c.4084C>T | p.Arg1362Cys | missense_variant | 23/27 | NP_001333901.1 | ||
VWDE | NM_001346973.2 | c.3619C>T | p.Arg1207Cys | missense_variant | 23/27 | NP_001333902.1 | ||
VWDE | NR_144534.2 | n.5251C>T | non_coding_transcript_exon_variant | 26/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWDE | ENST00000275358.8 | c.4429C>T | p.Arg1477Cys | missense_variant | 25/29 | 5 | NM_001135924.3 | ENSP00000275358 | P1 | |
VWDE | ENST00000452576.6 | c.*1193C>T | 3_prime_UTR_variant, NMD_transcript_variant | 26/30 | 1 | ENSP00000401687 | ||||
VWDE | ENST00000521169.5 | c.*2807C>T | 3_prime_UTR_variant, NMD_transcript_variant | 22/26 | 5 | ENSP00000428810 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152158Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152158
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000127 AC: 2AN: 157738Hom.: 0 AF XY: 0.0000240 AC XY: 2AN XY: 83248
GnomAD3 exomes
AF:
AC:
2
AN:
157738
Hom.:
AF XY:
AC XY:
2
AN XY:
83248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000164 AC: 23AN: 1399632Hom.: 0 Cov.: 34 AF XY: 0.0000159 AC XY: 11AN XY: 690312
GnomAD4 exome
AF:
AC:
23
AN:
1399632
Hom.:
Cov.:
34
AF XY:
AC XY:
11
AN XY:
690312
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74458
GnomAD4 genome
AF:
AC:
3
AN:
152276
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2023 | The c.4429C>T (p.R1477C) alteration is located in exon 25 (coding exon 25) of the VWDE gene. This alteration results from a C to T substitution at nucleotide position 4429, causing the arginine (R) at amino acid position 1477 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Uncertain
N;.
REVEL
Benign
Sift
Benign
D;.
Sift4G
Uncertain
T;T
Polyphen
B;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0174);.;
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -33
Find out detailed SpliceAI scores and Pangolin per-transcript scores at